Melinta Therapeutics (United States)
Melinta Therapeutics is an American biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings. The company is located in Parsippany, New Jersey. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Melinta Therapeutics (United States), United States, covering academic research published from 2002 to 2025. Read More.
Open Access Percentage
64%
Total
Publications
222
Total Open
Publications
142
Total
Citations
6.5K
Open Access
Percentage
64%
Total
Publications
222
Total Open
Publications
142
Total
Citations
6.5K
Breakdown
Publisher Open
21%
Both
35%
Other Platform Open
8%
Closed
36%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 52%
65
Hybrid 24%
30
No Guarantees 24%
30
Other Platform Open
Domain 79%
74
Institution 31%
29
Other Internet 6%
6
Preprint 2%
2
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 75 |
doaj.org OAI-PMH Repository | Institution | 15 |
Unknown Repository | Other Internet | 3 |
LA Referencia | Institution | 3 |
DOI | Other Internet | 3 |
University of Edinburgh | Institution | 2 |
Universitat Pompeu Fabra | Institution | 2 |
National Institutes of Health | Institution | 2 |
Indiana University | Institution | 2 |
Europe PMC | Domain | 2 |